125 related articles for article (PubMed ID: 12059891)
1. Plasma cholinesterase activity and duration of action of mivacurium in phenotypically normal patients.
ØStergaard D; Ibsen M; Skovgaard L; Viby-Mogensen J
Acta Anaesthesiol Scand; 2002 Jul; 46(6):679-83. PubMed ID: 12059891
[TBL] [Abstract][Full Text] [Related]
2. Influence of plasma cholinesterase activity on recovery from mivacurium-induced neuromuscular blockade in phenotypically normal patients.
Ostergaard D; Jensen FS; Jensen E; Skovgaard LT; Viby-Mogensen J
Acta Anaesthesiol Scand; 1992 Oct; 36(7):702-6. PubMed ID: 1441874
[TBL] [Abstract][Full Text] [Related]
3. Enzymatic antagonism of mivacurium-induced neuromuscular blockade by human plasma cholinesterase.
Naguib M; Daoud W; el-Gammal M; Ammar A; Turkistani A; Selim M; Altamimi W; Sohaibani MO
Anesthesiology; 1995 Oct; 83(4):694-701. PubMed ID: 7574048
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and pharmacodynamics of mivacurium in patients phenotypically heterozygous for the usual and atypical plasma cholinesterase variants (UA).
Østergaard D; Viby-Mogensen J; Rasmussen SN; Gätke MR; Pedersen NA; Skovgaard LT
Acta Anaesthesiol Scand; 2003 Nov; 47(10):1219-25. PubMed ID: 14616318
[TBL] [Abstract][Full Text] [Related]
5. [Neuromuscular recovery following mivacurium is predictable in patients with severe systemic disease prognoses].
Blobner M; Busley R; Mann R; Jelen-Esselborn S; Kochs E
Anasthesiol Intensivmed Notfallmed Schmerzther; 1999 Oct; 34(10):638-41. PubMed ID: 10548961
[TBL] [Abstract][Full Text] [Related]
6. Influence of metoclopramide on plasma cholinesterase and duration of action of mivacurium.
Skinner HJ; Girling KJ; Whitehurst A; Nathanson MH
Br J Anaesth; 1999 Apr; 82(4):542-5. PubMed ID: 10472219
[TBL] [Abstract][Full Text] [Related]
7. The pharmacodynamics and pharmacokinetics of mivacurium in children.
ØStergaard D; Gätke MR; Berg H; Rasmussen SN; Viby-Mogensen J
Acta Anaesthesiol Scand; 2002 May; 46(5):512-8. PubMed ID: 12027844
[TBL] [Abstract][Full Text] [Related]
8. Edrophonium and human plasma cholinesterase combination for antagonism of mivacurium-induced neuromuscular block.
Naguib M; Samarkandi AH; Bakhamees HS; Turkistani A; Alharby SW
Br J Anaesth; 1996 Sep; 77(3):424-6. PubMed ID: 8949825
[TBL] [Abstract][Full Text] [Related]
9. Mivacurium-induced neuromuscular blockade in patients with atypical plasma cholinesterase.
Ostergaard D; Jensen FS; Jensen E; Skovgaard LT; Viby-Mogensen J
Acta Anaesthesiol Scand; 1993 Apr; 37(3):314-8. PubMed ID: 8390770
[TBL] [Abstract][Full Text] [Related]
10. Neostigmine but not edrophonium prolongs the action of mivacurium.
Symington MJ; Mirakhur RK; Kumar N
Can J Anaesth; 1996 Dec; 43(12):1220-3. PubMed ID: 8955970
[TBL] [Abstract][Full Text] [Related]
11. Decreased mivacurium requirements and delayed neuromuscular recovery during sevoflurane anesthesia in children and adults.
Bevan JC; Reimer EJ; Smith MF; Scheepers L deV ; Bridge HS; Martin GR; Bevan DR
Anesth Analg; 1998 Oct; 87(4):772-8. PubMed ID: 9768768
[TBL] [Abstract][Full Text] [Related]
12. Effect of metoclopramide on mivacurium-induced neuromuscular block.
Motamed C; Kirov K; Combes X; Dhonneur G; Duvaldestin P
Acta Anaesthesiol Scand; 2002 Feb; 46(2):214-6. PubMed ID: 11942874
[TBL] [Abstract][Full Text] [Related]
13. The influence of drug-induced low plasma cholinesterase activity on the pharmacokinetics and pharmacodynamics of mivacurium.
Ostergaard D; Rasmussen SN; Viby-Mogensen J; Pedersen NA; Boysen R
Anesthesiology; 2000 Jun; 92(6):1581-7. PubMed ID: 10839906
[TBL] [Abstract][Full Text] [Related]
14. Is the recovery profile of mivacurium independent of the rate of decay of its plasma concentration in patients with normal plasma cholinesterase activity?
Nijs N; Duvaldestin P; Slavov V; Dhonneur G
Acta Anaesthesiol Scand; 1998 Nov; 42(10):1175-9. PubMed ID: 9834800
[TBL] [Abstract][Full Text] [Related]
15. Prolonged neuromuscular block associated with mivacurium.
Fox MH; Hunt PC
Br J Anaesth; 1995 Feb; 74(2):237-8. PubMed ID: 7696077
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and pharmacodynamics of mivacurium in patients phenotypically homozygous for the atypical plasma cholinesterase variant: effect of injection of human cholinesterase.
Østergaard D; Viby-Mogensen J; Rasmussen SN; Gätke MR; Varin F
Anesthesiology; 2005 Jun; 102(6):1124-32. PubMed ID: 15915024
[TBL] [Abstract][Full Text] [Related]
17. Neuromuscular pharmacodynamics of mivacurium in adults with major burns.
Han TH; Martyn JA
Br J Anaesth; 2011 May; 106(5):675-9. PubMed ID: 21354998
[TBL] [Abstract][Full Text] [Related]
18. [Pharmacodynamics and clinical adverse effects of mivacurium. The effect of oral premedication with H1/H2 antagonists].
Mayer M; Doenicke A; Nebauer AE; Rosenberger C; Lorenz W; Peter K
Anaesthesist; 1993 Sep; 42(9):592-6. PubMed ID: 8105716
[TBL] [Abstract][Full Text] [Related]
19. Edrophonium requirements for reversal of deep neuromuscular block following infusion of mivacurium.
Miller DR; Bryson G; Martineau RJ; Kitts JB; Curran M; Bragg P; Watson JB; Hull K; Lindsay P
Can J Anaesth; 1995 Nov; 42(11):996-1002. PubMed ID: 8590511
[TBL] [Abstract][Full Text] [Related]
20. Mivacurium-induced prolonged neuromuscular block.
Sockalingam I; Green DW
Br J Anaesth; 1995 Feb; 74(2):234-6. PubMed ID: 7696076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
